Edwards Larry Todd - Insider Non-Derivative Transactions at Arcutis Biotherapeutics, Inc. (ARQT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 17, 2024, Edwards Larry Todd's relationship to Arcutis Biotherapeutics, Inc. (ARQT) is Officer (SVP Chief Commercial Officer), and currently has 140,360 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ARQT insiders.

Data Source: SEC.
Edwards Larry Todd - Insider Non-Derivative Transactions of ARQT Common Stock
Edwards Larry Todd - Insider Non-Derivative Transactions at ARQT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 18, 2024 Sell -- (Common Stock) 7640 8.98 140360
May 17, 2024 Acquisition -- (Common Stock) 60000 0 148000
Jan 13, 2024 Acquisition -- (Common Stock) 28000 0 88000
Sep 28, 2023 Acquisition -- (Common Stock) 60000 0 60000